Literature DB >> 18226046

Incidence of type 2 diabetes in southern Spain (Pizarra Study).

F Soriguer1, G Rojo-Martínez, M C Almaraz, I Esteva, M S Ruiz de Adana, S Morcillo, S Valdés, E García-Fuentes, E García-Escobar, I Cardona, J M Gomez-Zumaquero, G Olveira-Fuster.   

Abstract

BACKGROUND: Few European studies have used an oral glucose tolerance test (OGTT) to examine the incidence of type 2 diabetes. We determined the incidence of impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and type 2 diabetes in a population from southern Spain.
MATERIAL AND METHODS: A population-based cohort study was undertaken in Pizarra, Spain. Baseline data were recorded on age, sex, weight, height, waist and hip circumferences, and diabetes status for 1051 persons, of whom 910 were free of type 2 diabetes (at-risk sample). Of these, 714 completed the 6-year follow-up study. Body mass index, waist-to-hip ratio and weight increase since baseline were calculated. The homeostasis model assessment equations were used to estimate the indices of insulin resistance and beta-cell function. Each person received an OGTT at baseline and after 6 years.
RESULTS: Type 2 diabetes developed in 81 people for a total of 4253 person-years, representing an incidence of 19.1 cases per 1000 person-years (95% confidence interval, 15.3-23.6). Age and the presence of obesity, central obesity and carbohydrate metabolism disorders [IFG (cut off = 100 mg dL(-1), capillary blood glucose level), IGT or both] at baseline were significant markers for the onset of type 2 diabetes during follow-up. After adjusting for these variables, multivariate analysis showed weight increase, waist-to-hip ratio and the indices of insulin resistance and beta-cell function were significantly associated with the risk for type 2 diabetes.
CONCLUSIONS: The incidence of type 2 diabetes in a population from southern Spain is high. It is probably associated with the high prevalence of obesity and weight increase in this population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18226046     DOI: 10.1111/j.1365-2362.2007.01910.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  13 in total

1.  Association between glycemic index, glycemic load, and fructose with insulin resistance: the CDC of the Canary Islands study.

Authors:  Santiago Domínguez Coello; Antonio Cabrera de León; María C Rodríguez Pérez; Carlos Borges Álamo; Lourdes Carrillo Fernández; Delia Almeida González; Jezabel García Yanes; Ana González Hernández; Buenaventura Brito Díaz; Armando Aguirre-Jaime
Journal:  Eur J Nutr       Date:  2010-04-25       Impact factor: 5.614

2.  FINDRISC Modified for Latin America as a Screening Tool for Persons with Impaired Glucose Metabolism in Ciudad Bolívar, Venezuela.

Authors:  María Carolina Muñoz-González; Marcos M Lima-Martínez; Aura Nava; Gisuardo Trerotola; Mariela Paoli; Julio O Cabrera-Rego; Briggytte Gonzalez; Amilcairy Arciniegas; Javier Paez
Journal:  Med Princ Pract       Date:  2019-03-11       Impact factor: 1.927

3.  Incidence of register-based diabetes 10 years after a stepwise diabetes screening programme: the ADDITION-Denmark study.

Authors:  Signe S Rasmussen; Nanna B Johansen; Daniel R Witte; Knut Borch-Johnsen; Annelli Sandbaek; Torsten Lauritzen; Marit E Jørgensen
Journal:  Diabetologia       Date:  2016-02-08       Impact factor: 10.122

4.  Stearoyl-CoA desaturase-1 is associated with insulin resistance in morbidly obese subjects.

Authors:  Sara García-Serrano; Inmaculada Moreno-Santos; Lourdes Garrido-Sánchez; Carolina Gutierrez-Repiso; Jose M García-Almeida; Juan García-Arnés; Jose Rivas-Marín; Jose L Gallego-Perales; Eva García-Escobar; Gemma Rojo-Martinez; Francisco Tinahones; Federico Soriguer; Manuel Macias-Gonzalez; Eduardo García-Fuentes
Journal:  Mol Med       Date:  2010-11-05       Impact factor: 6.354

5.  Specific foot health-related quality-of-life impairment in patients with type II versus type I diabetes.

Authors:  Patricia Palomo-López; Marta Elena Losa-Iglesias; Ricardo Becerro-de-Bengoa-Vallejo; Daniel López-López; David Rodríguez-Sanz; Carlos Romero-Morales; César Calvo-Lobo
Journal:  Int Wound J       Date:  2018-08-30       Impact factor: 3.315

6.  Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study.

Authors:  C Langenberg; S Sharp; N G Forouhi; P W Franks; M B Schulze; N Kerrison; U Ekelund; I Barroso; S Panico; M J Tormo; J Spranger; S Griffin; Y T van der Schouw; P Amiano; E Ardanaz; L Arriola; B Balkau; A Barricarte; J W J Beulens; H Boeing; H B Bueno-de-Mesquita; B Buijsse; M D Chirlaque Lopez; F Clavel-Chapelon; F L Crowe; B de Lauzon-Guillan; P Deloukas; M Dorronsoro; D Drogan; P Froguel; C Gonzalez; S Grioni; L Groop; C Groves; P Hainaut; J Halkjaer; G Hallmans; T Hansen; J M Huerta Castaño; R Kaaks; T J Key; K T Khaw; A Koulman; A Mattiello; C Navarro; P Nilsson; T Norat; K Overvad; L Palla; D Palli; O Pedersen; P H Peeters; J R Quirós; A Ramachandran; L Rodriguez-Suarez; O Rolandsson; D Romaguera; I Romieu; C Sacerdote; M J Sánchez; A Sandbaek; N Slimani; I Sluijs; A M W Spijkerman; B Teucher; A Tjonneland; R Tumino; D L van der A; W M M Verschuren; J Tuomilehto; E Feskens; M McCarthy; E Riboli; N J Wareham
Journal:  Diabetologia       Date:  2011-06-30       Impact factor: 10.122

7.  ELOVL6 genetic variation is related to insulin sensitivity: a new candidate gene in energy metabolism.

Authors:  Sonsoles Morcillo; Gracia María Martín-Núñez; Gemma Rojo-Martínez; María Cruz Almaraz; Eva García-Escobar; María Luisa Mansego; Griselda de Marco; Felipe J Chaves; Federico Soriguer
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

8.  The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity.

Authors:  Petra I Lorenzo; Eugenia Martin Vazquez; Livia López-Noriega; Esther Fuente-Martín; José M Mellado-Gil; Jaime M Franco; Nadia Cobo-Vuilleumier; José A Guerrero Martínez; Silvana Y Romero-Zerbo; Jesús A Perez-Cabello; Sabrina Rivero Canalejo; Antonio Campos-Caro; Christian Claude Lachaud; Alejandra Crespo Barreda; Manuel Aguilar-Diosdado; Eduardo García Fuentes; Alejandro Martin-Montalvo; Manuel Álvarez Dolado; Franz Martin; Gemma Rojo-Martinez; David Pozo; Francisco J Bérmudez-Silva; Valentine Comaills; José C Reyes; Benoit R Gauthier
Journal:  Theranostics       Date:  2021-05-12       Impact factor: 11.556

9.  Impact of obesity-related genes in Spanish population.

Authors:  Fernando Martínez-García; María L Mansego; Gemma Rojo-Martínez; Griselda De Marco-Solar; Sonsoles Morcillo; Federico Soriguer; Josep Redón; Monica Pineda Alonso; Juan C Martín-Escudero; Richard S Cooper; Felipe J Chaves
Journal:  BMC Genet       Date:  2013-11-23       Impact factor: 2.797

10.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.